Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-29
DOI
10.1111/cas.14668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
- (2020) Michael J Pishvaian et al. LANCET ONCOLOGY
- Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
- (2020) Eric S Christenson et al. LANCET ONCOLOGY
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer
- (2020) Li Ding et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
- (2020) Przemysław Duda et al. Cells
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
- (2020) Dilireba Bolidong et al. Scientific Reports
- Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
- (2020) Takahiro Domoto et al. Cells
- Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities
- (2019) Vinod P. Balachandran et al. GASTROENTEROLOGY
- Chemotherapy for pancreatic cancer
- (2019) Christoph Springfeld et al. PRESSE MEDICALE
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- Isobologram Analysis: A Comprehensive Review of Methodology and Current Research
- (2019) Ruo-yue Huang et al. Frontiers in Pharmacology
- The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance
- (2018) Elke Tatjana Aristizabal Prada et al. ENDOCRINE-RELATED CANCER
- Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
- (2018) A. Prasanth Saraswati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer
- (2018) Claire Vennin et al. GASTROENTEROLOGY
- Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer
- (2018) Siddavaram Nagini et al. SEMINARS IN CANCER BIOLOGY
- Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction
- (2018) Firli R.P. Dewi et al. Oncotarget
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
- (2018) Albrecht Neesse et al. GUT
- Effect of ribonucleotide reductase M1 expression on overall survival in patients with pancreatic cancer receiving gemcitabine chemotherapy: A literature-based meta-analysis
- (2017) Q. L. Han et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Prognostic Implications of Expression Profiling for Gemcitabine-Related Genes (hENT1, dCK, RRM1, RRM2) in Patients With Resectable Pancreatic Adenocarcinoma Receiving Adjuvant Chemotherapy
- (2017) Marek Sierzega et al. PANCREAS
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
- (2016) Zhengle Zhang et al. CANCER LETTERS
- Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy
- (2016) Takahiro Domoto et al. CANCER SCIENCE
- RB1: a prototype tumor suppressor and an enigma
- (2016) Nicholas J. Dyson GENES & DEVELOPMENT
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clones
- (2015) Hiroshi Yoneyama et al. ANTI-CANCER DRUGS
- Combining targeted therapeutics in the era of precision medicine
- (2015) D Papadatos-Pastos et al. BRITISH JOURNAL OF CANCER
- Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
- (2015) Kentaro Minami et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Glycogen Synthase Kinase 3 Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
- (2014) Y. Chikano et al. MOLECULAR CANCER THERAPEUTICS
- Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O 6 -methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
- (2013) Ilya V. Pyko et al. CARCINOGENESIS
- Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
- (2013) Ayako Kitano et al. PLoS One
- DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells
- (2012) Yuriko Saiki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
- (2011) Takeo Shimasaki et al. JOURNAL OF GASTROENTEROLOGY
- Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
- (2011) Stephanie Alexander et al. TRENDS IN MOLECULAR MEDICINE
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search